AbbVie Jumps After Hiking Its Outlook On The Back Of Strong Immunology Sales
AbbVie stock jumped Friday after the drugmaker raised its 2025 earnings outlook following a strong quarterly report. The post AbbVie Jumps After Hiking Its Outlook On The Back Of Strong Immunology Sales appeared first on Investor's Business Daily.
AbbVie stock jumped Friday after the drugmaker raised its 2025 earnings outlook following a strong quarterly report.
The post AbbVie Jumps After Hiking Its Outlook On The Back Of Strong Immunology Sales appeared first on Investor's Business Daily.
iShook Opinion
"iShook Opinion" by Beni E Rachmanov, CEO & Founder of iShook. Explore captivating perspectives on entertainment, lifestyle, and sports at ishookdaily.com. Your go-to for engaging insights.
